WHO ICTRP trial
Based on RhoA/ROCK signaling pathway, the mechanism of Xiaoshuan Changrong…
ChiCTR2200058501 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200058501 |
|---|---|
| Public title | Based on RhoA/ROCK signaling pathway, the mechanism of Xiaoshuan Changrong capsule on cerebral infarction convalescence was studied |
| Scientific title | Based on RhoA/ROCK signaling pathway, the mechanism of Xiaoshuan Changrong capsule on cerebral infarction convalescence was studied |
| Primary sponsor | Shanxi University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | stroke |
| Interventions | Western medicine group :Western medicine;Healthy control group:None;Western medicine and Xiaoshuan Changrong capsule group:Western medicine and Xiaoshuan Changrong capsule |
| Registration date | Apr 10, 2022 |
| Target size | Western medicine group :50;Healthy control group:50;Western medicine and… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: